Keith Meister has served on has served on the Board of Directors at GeneDx (formerly Sema4) s since January 2022.
Currently, Keith is also Managing Partner and Chief Investment Officer of Corvex Management LP, which he founded in December 2010.
Prior to founding Corvex, Keith served as Chief Executive Officer and then Principal Executive Officer and Vice Chairman of the Board of Icahn Enterprises from August 2003 to August 2010. From its launch in November 2004 to August 2010, he also served as Senior Managing Director of the General Partners of Icahn Partners LP and affiliated funds. Prior to joining the Icahn Organization, Keith served as Co‐President of J Net Ventures from January 2000 through September 2001. Prior to launching J Net Ventures, he worked at NorthStar Capital and Lazard Freres.
In addition to GeneDx, Keith currently serves on the Board of Directors for MGM Resorts and BetMGM. He has previously served as a director on numerous other public boards including Yum! Brands, Inc., The Williams Companies, The ADT Corporation, Ralcorp Holdings, and Motorola/Motorola Mobility, among others. He is also Chairman of the Board of Directors for Harlem Children’s Zone and a member of the Board of Trustees for the American Museum of Natural History.
Keith received an A.B. in government, cum laude, from Harvard College in 1995.
What is Keith A. Meister's net worth?
The estimated net worth of Keith A. Meister is at least $872.18 million as of September 11th, 2025. Mr. Meister owns 5,385,478 shares of GeneDx stock worth more than $872,178,162 as of December 5th. This net worth approximation does not reflect any other investments that Mr. Meister may own. Learn More about Keith A. Meister's net worth.
How do I contact Keith A. Meister?
Has Keith A. Meister been buying or selling shares of GeneDx?
Keith A. Meister has not been actively trading shares of GeneDx during the past quarter. Most recently, on Thursday, May 8th, Keith A. Meister bought 100,000 shares of GeneDx stock. The stock was acquired at an average cost of $56.01 per share, with a total value of $5,601,000.00. Following the completion of the transaction, the director now directly owns 3,008,629 shares of the company's stock, valued at $168,513,310.29. Learn More on Keith A. Meister's trading history.
Who are GeneDx's active insiders?
GeneDx's insider roster includes Shawn Assad (CAO), Daniel Clark (General Counsel), James Coffin (COO), Kevin Feeley (CFO), Keith Meister (Director), Richard Pfenniger, Jr. (Director), Richard Pfenniger, Jr. (Director), Anthony Prentice (Insider), Isaac Ro (CFO), Jason Ryan (Chairman of the Board), Eric Schadt (CEO), and Katherine Stueland (CEO). Learn More on GeneDx's active insiders.
Are insiders buying or selling shares of GeneDx?
In the last year, GeneDx insiders bought shares 1 times. They purchased a total of 100,000 shares worth more than $5,601,000.00. In the last year, insiders at the sold shares 38 times. They sold a total of 883,497 shares worth more than $100,107,549.19. The most recent insider tranaction occured on November, 24th when Director Joshua Ruch sold 38,000 shares worth more than $6,094,060.00. Insiders at GeneDx own 29.6% of the company.
Learn More about insider trades at GeneDx. Information on this page was last updated on 11/24/2025.
